STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.

Revenue
+8.79%
EPS
+12.8%
Free cash flow
+43.6%
Total debt
−0.21%

Quarter to September 2026, against a year earlier

253.00 1.12 −0.44%
Market cap
$24.8B
P/E
30.0×
Fwd P/E
25.1×
Dividend yield
1.02%
F-score
9/9
Altman Z
5.10
Beneish M
−2.68
Dividend safety
86/100

STERIS plc (STE) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, STERIS plc (STE) trades at a P/E ratio of 30.0×. Over the past ten years it has ranged from 0.0× (March 2023) to 203× (June 2023); the current reading is higher than 16% of that period. That is above the Medical Devices industry median of 25.6× and above the Healthcare sector median of 25.2×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2026 27.8× (23.64%)
FY2025 36.4× (36.96%)
FY2024 57.7× (67.11%)
FY2023 175× 75.65%
FY2022 99.9× 143.36%
FY2021 41.1× 41.07%
FY2020 29.1× (17.56%)
FY2019 35.3× 33.02%
FY2018 26.5× (51.10%)
FY2017 54.3× 13.80%

Quarterly newest first

Period P/E ratio Change
Sep 2026 24.8× (3.21%)
Jun 2026 25.6× (7.68%)
Mar 2026 27.8× (21.21%)
Dec 2025 35.3× (0.39%)
43 more quarters

Against its own ten years

Low 0.0× High 203×
Ten-year median 38.1×
Current reading's percentile 10

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on STE